Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Human thymus has stem cells that can self-renew and maintain their identity.

The method effectively delivers vaccines through the skin without needles.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Clonally expanded CD8+ T cells cause alopecia areata.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

Hair follicle cells help maintain and support stem cells and blood cell formation.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Targeting specific cell interactions may help treat skin fibrosis.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Low CD4 counts in HIV patients are linked to more skin disorders.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.